Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinson’s Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinson’s disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025. December 5, 2024 Irvin Jackson Add Your CommentsThe U.S. District Judge presiding over hundreds of federal lawsuits over side effects of Ozempic, Wegovy and other similar diabetes and weight loss drugs has scheduled a series of status conferences in 2025, as the parties address early motions to dismiss and discovery focused on a series of “cross cutting” issues that are expected to impact large numbers of claims.There are currently about 1,300 product liability lawsuits being pursued against the manufacturers of Ozempic, Wegovy, Mounjaro, Zebpound, Trulicity and other drugs that are part of a new class of medications known as glucacon-like peptide-1 (GLP-1) receptor agonists, each raising similar allegations that drug manufacturers failed to warn users and the medical community about serious gastrointestinal side effects linked to the drugs’ delayed gastric emptying effects.However, given the widespread use of the drugs, which some estimates suggest have been prescribed to about 12% of the U.S. population in recent years, it is expected that the size and scope of the litigation will rapidly increase in 2025, with tens of thousands of individuals likely to present claims after developing gastroparesis, stomach paralysis, ileus, intestinal obstructions and other complications.Find Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONFind Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONGiven common questions of fact and law raised in the Ozempic lawsuits, Wegovy lawsuits, Mounjaro lawsuits, and other complaints filed throughout the federal court system involving the class of drugs, all federal GLP-1 lawsuits have been centralized as part of a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where they are currently being overseen by U.S. District Judge Karen Marston for coordinated and centralized pretrial proceedings.Before scheduling a series of representative “bellwether” trials, which are typically selected early in MDL proceedings to help the parties gauge how juries may respond to certain evidence and testimony that will be repeated through the litigation, Judge Marston decided to focus the initial discovery and pretrial proceedings on resolving a number of “cross cutting” issues in the Ozempic lawsuits.These issues include determining whether plaintiffs will be required to provide specific gastroparesis diagnostic testing to establish that they have suffered that specific stomach injury. In addition, the court will decide whether the lawsuits are preempted by federal law and evaluate the general causation evidence linking the Ozempic drugs to the claimed gastrointestinal injuries, including gastroparesis, small bowel obstruction, ileus and gallbladder injuries.On December 3, Judge Marston issued a scheduling order (PDF) outlining deadlines for presenting motions and briefs regarding the preemption issue, indicating that the drug manufacturers must file any motion to dismiss the master complaint by January 24, 2025.This motion is expected to include arguments that federal law prevented the drug makers from independently updating the drug warning labels, and therefore the state-law based failure to warn claims are preempted.According to the order, Plaintiffs must file their response to any motion to dismiss by March 18, 2025, with Defendants deadline for filing a reply by April 14, 2025. The court is then expected to schedule oral arguments, and a decision on this first “cross cutting” issue could be resolved by the end of the year.To address the issue of general causation, Judge Marston previously released an order (PDF) setting a fact discovery deadline of July 2, 2025, with each side exchanging expert reports throughout July and August 2025.The parties are scheduled to meet with Judge Marston on December 17, and last week the Court issued another order (PDF) establishing a series of monthly Ozempic lawsuit status conferences in 2025, including:January 14, 2025February 24, 2025March 18, 2025April 21, 2025May 19, 2025June 24, 2025July 29, 2025September 3, 2025As a result of the current schedule, it is not expected that the first Ozempic lawsuits will go before a federal jury until at least late 2026 or early 2027, which may help the parties negotiate Ozempic settlements to resolve large numbers of claims in the future. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Diabetes, Diabetes Drugs, Gastroparesis, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Trulicity, Wegovy, Weight Loss Image Credit: Shutterstock: KK Stock Find Out If You Qualify for Ozempic or Wegovy CompensationMore Ozempic, Wegovy and Mounjaro Lawsuit Stories FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026 Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks October 30, 2026 GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind October 13, 2026 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Parkinson’s Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: today)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSON’S DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinson’s Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: yesterday)A Washington woman’s lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: 2 days ago)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026
Parkinson’s Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: today)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSON’S DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinson’s Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: yesterday)A Washington woman’s lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: 2 days ago)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)